This interactive tool gives industry professionals the power to sort and view the population of TIL clinical trials in various configurations, shedding light on important trends, developments and advancements.
TIL therapies exploit a subset of native T-cells that are able to infiltrate and fight tumors. This visualization allows you to view trials1 that incorporate this cell type.
This clinical trial visualization tool was developed by and is the property of Terumo BCT, Inc. This tool may not be copied, reproduced or used without permission from Terumo BCT, Inc.
*Trials containing incomplete data may be eliminated from certain views.
1Source data pulled from ClinicalTrials.gov on 20 July 2017.